New York Life Trust’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-1,095
Closed -$85K 226
2016
Q2
$85K Sell
1,095
-528
-33% -$42.1K 0.41% 92
2016
Q1
$133K Buy
1,623
+9
+0.6% +$732 0.57% 45
2015
Q4
$144K Buy
+1,614
New +$137K 0.62% 44
2015
Q3
Sell
-354
Closed -$30K 210
2015
Q2
$30K Sell
354
-786
-69% -$69.4K 0.12% 167
2015
Q1
$103K Buy
+1,140
New +$98.1K 0.41% 111
2014
Q4
Sell
-1,881
Closed -$141K 203
2014
Q3
$141K Sell
1,881
-36
-2% -$2.62K 0.58% 53
2014
Q2
$131K Buy
1,917
+65
+4% +$4.42K 0.55% 64
2014
Q1
$130K Sell
1,852
-32
-2% -$2.23K 0.57% 58
2013
Q4
$126K Sell
1,884
-282
-13% -$17.2K 0.57% 51
2013
Q3
$113K Buy
+2,166
New +$110K 0.57% 55

Other funds holding CAH

New York Life Trust's CAH Position: Q3 2016 in Review

New York Life Trust sold out of Cardinal Health (CAH) in Q3 2016, closing a stake of 1,095 shares — an estimated $85K sold.

New York Life Trust first reported a position in CAH in Q3 2013 and held it in 10 quarters. The position peaked at $144K in Q4 2015. 773 funds tracked by Wall St. Rank hold CAH as of Q3 2016.

  • New York Life Trust reported no remaining Cardinal Health position as of Q3 2016 after selling out during the quarter.
  • New York Life Trust sold 1,095 Cardinal Health shares in Q3 2016, an estimated $85K.
  • New York Life Trust first reported a position in Cardinal Health in Q3 2013 and held it in 10 quarters.
  • New York Life Trust's Cardinal Health position peaked at $144K in Q4 2015.
  • 773 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2016.

Based on New York Life Trust's 13F filing for Q3 2016, filed 8 Nov 2016.